Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1044

1.

Durable treatment-free remission after high-dose cyclophosphamide therapy for previously untreated severe aplastic anemia.

Brodsky RA, Sensenbrenner LL, Smith BD, Dorr D, Seaman PJ, Lee SM, Karp JE, Brodsky I, Jones RJ.

Ann Intern Med. 2001 Oct 2;135(7):477-83.

PMID:
11578150
2.
3.

High-dose cyclophosphamide as salvage therapy for severe aplastic anemia.

Brodsky RA, Chen AR, Brodsky I, Jones RJ.

Exp Hematol. 2004 May;32(5):435-40.

PMID:
15145211
4.

High-dose cyclophosphamide to treat severe aplastic anemia.

[No authors listed]

Ann Intern Med. 2001 Oct 2;135(7):S-1. No abstract available.

PMID:
11596572
5.
6.
7.

Treatment of adults with severe aplastic anemia: primary therapy with antithymocyte globulin (ATG) and rescue of ATG failures with bone marrow transplantation.

Crump M, Larratt LM, Maki E, Curtis JE, Minden MD, Meharchand JM, Lipton JH, Messner HA.

Am J Med. 1992 Jun;92(6):596-602.

PMID:
1605140
8.

Treatment of hepatitis-associated aplastic anemia with high-dose cyclophosphamide.

Savage WJ, DeRusso PA, Resar LM, Chen AR, Higman MA, Loeb DM, Jones RJ, Brodsky RA.

Pediatr Blood Cancer. 2007 Dec;49(7):947-51.

PMID:
17252566
9.
10.

Outcome of adult severe or very severe aplastic anemia treated with immunosuppressive therapy compared with bone marrow transplantation: multicenter trial.

Ahn MJ, Choi JH, Lee YY, Choi IY, Kim IS, Yoon SS, Park SY, Kim BK, Suh C, Son HJ, Jung CW, Lee JH, Sung JM, Im SA, Oh D, Jung SY, Yoon HJ, Cho KS, Lee JA, Yuh YJ, Kim SR, Ki M.

Int J Hematol. 2003 Aug;78(2):133-8.

PMID:
12953807
11.

High-dose cyclophosphamide treatment for refractory severe aplastic anemia in children.

Audino AN, Blatt J, Carcamo B, Castaneda V, Dinndorf P, Wang WC, Whitlock JA, Hord JD.

Pediatr Blood Cancer. 2010 Feb;54(2):269-72. doi: 10.1002/pbc.22312.

PMID:
19827142
13.

Improved survival in severe acquired aplastic anemia of childhood.

Fouladi M, Herman R, Rolland-Grinton M, Jones-Wallace D, Blanchette V, Calderwood S, Doyle J, Halperin D, Leaker M, Saunders EF, Zipursky A, Freedman MH.

Bone Marrow Transplant. 2000 Dec;26(11):1149-56.

14.

Successful allogeneic hematopoietic stem cell transplantation using triple agent immunosuppression in severe aplastic anemia patients.

Kim HJ, Park CY, Park YH, Kim YJ, Kim DW, Min WS, Kim CC.

Bone Marrow Transplant. 2003 Jan;31(2):79-86.

PMID:
12621487
15.

Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.

Führer M, Burdach S, Ebell W, Gadner H, Haas R, Harbott J, Janka-Schaub G, Klingebiel T, Kremens B, Niemeyer C, Rampf U, Reiter A, Ritter J, Schulz A, Walther U, Zeidler C, Bender-Götze C.

Klin Padiatr. 1998 Jul-Aug;210(4):173-9.

PMID:
9743949
16.

[Experience in the use of allogeneic bone marrow transplantation in severe forms of aplastic anemia at the Byelorussian hematological center].

Uss AL, Zmachinskiĭ VA, Milanovich NF, Skriagin AE, Batan ZE, Dziuba EV, Mitskevich PB, Smirnova LA.

Ter Arkh. 1999;71(7):69-72. Russian.

PMID:
10481871
17.
18.

Allografting in patients with severe, refractory aplastic anemia using peripheral blood stem cells and a fludarabine-based conditioning regimen: the Mexican experience.

Gómez-Almaguer D, Vela-Ojeda J, Jaime-Pérez JC, Gutiérrez-Aguirre CH, Cantú-Rodríguez OG, Sobrevilla-Calvo P, Rivas-Vera S, Gómez-Rangel JD, Ruiz-Argüelles GJ.

Am J Hematol. 2006 Mar;81(3):157-61.

19.

High-dose cyclophosphamide for refractory autoimmune hemolytic anemia.

Moyo VM, Smith D, Brodsky I, Crilley P, Jones RJ, Brodsky RA.

Blood. 2002 Jul 15;100(2):704-6.

20.

Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study.

Locasciulli A, Bruno B, Rambaldi A, Saracco P, Dufour C, Finelli C, Sica S, Varotto S, Arcese W, Locatelli F, Soligo D, Bacigalupo A; GITMO prospective randomized study..

Haematologica. 2004 Sep;89(9):1054-61.

Supplemental Content

Support Center